Ge Healthcare Technologies Share Price (NASDAQ: GEHC)

$73.41

▲

-0.25

(-0.34%)

Last updated on August 16, 2025 at 1:29 AM IST

$₹

Check the interactive Ge Healthcare Technologies Stock chart to analyse performance

Ge Healthcare Technologies stock performance

as on August 16, 2025 at 1:29 AM IST

Today's Low:$73.11
Today's High:$74.49
$73.41
0.41%
Downside
Day's Volatility :1.85%
Upside
1.45%
52 Weeks Low:$57.65
52 Weeks High:$94.80
$73.41
21.47%
Downside
52 Weeks Volatility :39.19%
Upside
22.56%

Ge Healthcare Technologies Stock Returns

Period	Ge Healthcare Technologies Inc.	Index (Russel 2000)
3 Months	0.42%	0.0%
6 Months	-20.78%	0.0%
1 Year	-14.23%	0.0%
3 Years	21.36%	-11.0%

Ge Healthcare Technologies Inc. Key Stats

Check Ge Healthcare Technologies key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$73.66
Open	$74.0
Today's High	$74.49
Today's Low	$73.11
Market Capitalization	$33.6B
Today's Volume	$2.9M
52 Week High	$94.8
52 Week Low	$57.65
Revenue TTM	$20.0B
EBITDA	$3.7B
Earnings Per Share (EPS)	$4.88
PE Ratio	15.09
Dividend Yield	0.13%
Profit Margin	11.22%
Quarterly Earnings Growth YOY	0.14%
Return On Equity TTM	25.8%

Stock Returns calculator for Ge Healthcare Technologies Stock including INR - Dollar returns

The Ge Healthcare Technologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Ge Healthcare Technologies investment value today

Current value as on today

₹89,979

Returns

₹10,021

(-10.02%)

Returns from Ge Healthcare Technologies Stock

₹14,231 (-14.23%)

Dollar Returns*

₹4,210 (+4.21%)

Indian investors sentiment towards Ge Healthcare Technologies Stock

10.2%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Investment in Ge Healthcare Technologies Shares from India has grown by 10.2% over the past 30 days, indicating increased transactional activity.

83%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Ge Healthcare Technologies Stock from India on INDmoney has increased by 83% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Ge Healthcare Technologies Stock

Name	Shares Held	Change in Shares	% of Assets
ICICI Prudential NASDAQ 100 Index Fund Direct Growth	6518	-235.23	0.19%
Motilal Oswal S&P 500 Index Fund Direct Growth	3701	-33.53	0.06%
ICICI Prudential US Bluechip Equity Fund Direct Plan Growth	120200	-	2.30%

Analyst Recommendation on Ge Healthcare Technologies Stock

Rating

Trend

Buy

68%Buy

31%Hold

0%Sell

Based on 22 Wall street analysts offering stock ratings for Ge Healthcare Technologies(by analysts ranked 0 to 5 stars)

Ge Healthcare Technologies Share Price Target

What analysts predicted

Upside of 19.88%

Target:

$88.00

Current:

$73.41

Ge Healthcare Technologies share price target is $88.00, a slight Upside of 19.88% compared to current price of $73.41 as per analysts' prediction.

Ge Healthcare Technologies Stock Insights

Price Movement
In the last 6 months, GEHC stock has moved down by -20.4%
Increasing Revenue
Ge Healthcare Technologies Inc. has shown positive revenue trends over the last two quarters. The revenue increased from $4.77 billion to $5.00 billion, which represents an average increase of 4.6% per quarter.
Decreasing Net Profit
GE Healthcare Technologies Inc. has seen a decline in its net profit over the last three quarters. The net profit has decreased from $720.0 million to $486.0 million, reflecting an average quarterly decrease of 17.8%.
GEHC vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 82.3% return, outperforming this stock by 95.7%
Price to Sales
Ge Healthcare Technologies Inc. has a Price-to-Sales Ratio of 1.7, meaning that investors are willing to pay $1.70 for every $1 of sales the company generates. In comparison, Doximity, Inc. has a much higher Price-to-Sales Ratio of 20.7, indicating that investors are willing to pay $20.70 for every $1 of sales. This suggests that investors may value Doximity, Inc. significantly more than Ge Healthcare Technologies Inc. based on their sales performance.

Ge Healthcare Technologies Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$16.6B	-
Net Income	$1.5B	-
Net Profit Margin	9.16%	-

	FY20	Y/Y Change
Revenue	$17.2B	↑ 3.19%
Net Income	$13.8B	↑ 808.53%
Net Profit Margin	80.67%	↑ 71.51%

	FY21	Y/Y Change
Revenue	$17.6B	↑ 2.45%
Net Income	$2.2B	↓ 83.77%
Net Profit Margin	12.78%	↓ 67.89%

	FY22	Y/Y Change
Revenue	$18.3B	↑ 4.3%
Net Income	$1.9B	↓ 14.73%
Net Profit Margin	10.45%	↓ 2.33%

	FY23	Y/Y Change
Revenue	$19.6B	↑ 6.6%
Net Income	$3.1B	↑ 62.0%
Net Profit Margin	15.88%	↑ 5.43%

	FY24	Y/Y Change
Revenue	$19.7B	↑ 0.61%
Net Income	$2.0B	↓ 35.79%
Net Profit Margin	10.13%	↓ 5.75%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$4.7B	↓ 10.68%
Net Income	$374.0M	↓ 7.2%
Net Profit Margin	8.04%	↑ 0.3%

	Q2 FY24	Q/Q Change
Revenue	$4.8B	↑ 4.06%
Net Income	$428.0M	↑ 14.44%
Net Profit Margin	8.84%	↑ 0.8%

	Q3 FY24	Q/Q Change
Revenue	$4.9B	↑ 0.5%
Net Income	$471.0M	↑ 10.05%
Net Profit Margin	9.69%	↑ 0.85%

	Q4 FY24	Q/Q Change
Revenue	$5.3B	↑ 9.38%
Net Income	$720.0M	↑ 52.87%
Net Profit Margin	13.54%	↑ 3.85%

	Q1 FY25	Q/Q Change
Revenue	$4.8B	↓ 10.19%
Net Income	$564.0M	↓ 21.67%
Net Profit Margin	11.81%	↓ 1.73%

	Q2 FY25	Q/Q Change
Revenue	$5.0B	↑ 4.79%
Net Income	$486.0M	↓ 13.83%
Net Profit Margin	9.71%	↓ 2.1%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$6.5B	-

	FY20	Y/Y Change
Profit	$6.8B	↑ 3.34%

	FY21	Y/Y Change
Profit	$7.2B	↑ 6.01%

	FY22	Y/Y Change
Profit	$7.2B	↑ 0.07%

	FY23	Y/Y Change
Profit	$7.9B	↑ 10.35%

	FY24	Y/Y Change
Profit	$8.2B	↑ 3.57%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$1.9B	↓ 11.78%

	Q2 FY24	Q/Q Change
Profit	$2.0B	↑ 5.26%

	Q3 FY24	Q/Q Change
Profit	$2.0B	↑ 1.2%

	Q4 FY24	Q/Q Change
Profit	$2.3B	↑ 12.29%

	Q1 FY25	Q/Q Change
Profit	$2.0B	↓ 11.56%

	Q2 FY25	Q/Q Change
Profit	$2.0B	↓ 1.34%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$2.0B	-
Investing Cash Flow	$-325.0M	-
Financing Cash Flow	$-1.6B	-

	FY20	Y/Y Change
Operating Cash Flow	$1.7B	↓ 15.18%
Investing Cash Flow	$20.0B	↓ 6249.54%
Financing Cash Flow	$-21.5B	↑ 1268.74%

	FY21	Y/Y Change
Operating Cash Flow	$1.6B	↓ 4.74%
Investing Cash Flow	$-1.8B	↓ 108.81%
Financing Cash Flow	$-263.0M	↓ 98.78%

	FY22	Y/Y Change
Operating Cash Flow	$2.1B	↑ 31.49%
Investing Cash Flow	$-398.0M	↓ 77.4%
Financing Cash Flow	$-822.0M	↑ 212.55%

	FY23	Y/Y Change
Operating Cash Flow	$2.1B	↓ 0.57%
Investing Cash Flow	$-558.0M	↑ 40.2%
Financing Cash Flow	$-478.0M	↓ 41.85%

	FY24	Y/Y Change
Operating Cash Flow	$2.0B	↓ 7.14%
Investing Cash Flow	$-914.0M	↑ 63.8%
Financing Cash Flow	$-573.0M	↑ 19.87%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$419.0M	↓ 60.1%
Investing Cash Flow	$-188.0M	↑ 113.64%
Financing Cash Flow	$-153.0M	↓ 83.0%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-119.0M	↓ 128.4%
Investing Cash Flow	$-349.0M	↑ 85.64%
Financing Cash Flow	$-57.0M	↓ 62.75%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$738.0M	↓ 720.17%
Investing Cash Flow	$-137.0M	↓ 60.74%
Financing Cash Flow	$914.0M	↓ 1703.51%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$913.0M	↑ 23.71%
Investing Cash Flow	$-240.0M	↑ 75.18%
Financing Cash Flow	$-1.3B	↓ 239.72%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$250.0M	↓ 72.62%
Investing Cash Flow	$-407.0M	↑ 69.58%
Financing Cash Flow	$-286.0M	↓ 77.6%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-250.0M	↓ 200.0%
Investing Cash Flow	$-223.0M	↓ 45.21%
Financing Cash Flow	$1.4B	↓ 575.87%

Ge Healthcare Technologies Technicals Summary

Sell

Neutral

Buy

Ge Healthcare Technologies is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Ge Healthcare Technologies Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ge Healthcare Technologies Inc.	-1.01%	-20.78%	-14.23%	21.36%	21.36%
Tempus Ai	27.22%	-9.95%	28.1%	83.35%	83.35%
Doximity, Inc.	8.15%	-16.39%	80.85%	97.39%	22.94%
Veeva Systems Inc.	-0.14%	20.51%	44.43%	28.0%	5.14%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ge Healthcare Technologies Inc.	15.09	15.09	3.44	4.51	0.26	0.06	0.0	21.27
Tempus Ai	30.86	30.86	NA	-0.78	-0.98	-0.12	NA	1.78
Doximity, Inc.	54.31	54.31	2.42	1.31	0.24	0.13	NA	5.47
Veeva Systems Inc.	59.27	59.27	1.49	6.45	0.14	0.07	NA	38.11

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ge Healthcare Technologies Inc.	Buy	$33.6B	21.36%	15.09	11.22%
Tempus Ai	NA	$11.5B	83.35%	30.86	-20.98%
Doximity, Inc.	Hold	$11.9B	22.94%	54.31	39.88%
Veeva Systems Inc.	Buy	$45.6B	5.14%	59.27	27.34%

Ge Healthcare Technologies Dividend announcements

Ge Healthcare Technologies Dividends September, 2025
In the quarter ending September,2025. Ge Healthcare Technologies has declared dividend of $0.04

About Ge Healthcare Technologies Inc.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Organization	Ge Healthcare Technologies
Employees	53000
CEO	Mr. Roland Rott
Industry	Healthcare

Key Management of Ge Healthcare Technologies Inc.

Name	Title
Mr. Peter J. Arduini	President, CEO & Director
Mr. James K. Saccaro	VP & CFO
Dr. Taha Kass-Hout M.D., M.S.	Chief Science & Technology Officer
Mr. Frank R. Jimenez Esq.	VP, General Counsel & Corporate Secretary
Mr. Roland Rott	President & CEO of Imaging
Mr. George Andrew Newcomb	Controller & Chief Accounting Officer
Mr. Jahid Khandaker	Chief Information Officer
Ms. Carolynne Borders	Chief Investor Relations Officer
Ms. Rana Strellis	Chief Corporate Marketing & Communications Officer
Mr. Adam Y. Holton	Chief People Officer

Important FAQs about investing in GEHC Stock from India :

What is Ge Healthcare Technologies share price today?

Ge Healthcare Technologies share price today is $73.41 as on August 16, 2025 at 1:29 AM IST at the close of the market. Ge Healthcare Technologies share today touched a day high of $74.49 and a low of $73.11.

What is the 52 week high and 52 week low for Ge Healthcare Technologies share?

Ge Healthcare Technologies share touched a 52 week high of $94.80 and a 52 week low of $57.65. Ge Healthcare Technologies stock price today, August 16, 2025 at 1:29 AM IST is trending at $73.41, lower by 22.56% versus the 52 week high.

How to invest in Ge Healthcare Technologies Stock (GEHC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ge Healthcare Technologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ge Healthcare Technologies Shares that will get you 0.0204 shares as per Ge Healthcare Technologies share price of $73.41 per share as on August 16, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Ge Healthcare Technologies Stock (GEHC) from India?

Indian investors can start investing in Ge Healthcare Technologies (GEHC) shares with as little as ₹87.492 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Ge Healthcare Technologies stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Ge Healthcare Technologies share’s latest price of $73.41 as on August 16, 2025 at 1:29 AM IST, you will get 0.1362 shares of Ge Healthcare Technologies. Learn more about fractional shares .

What are the returns that Ge Healthcare Technologies has given to Indian investors in the last 5 years?

Ge Healthcare Technologies stock has given 21.36% share price returns and 17.06% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?